306 related articles for article (PubMed ID: 11309459)
21. Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.
Decker HJ; Neuhaus C; Jauch A; Speicher M; Ried T; Bujard M; Brauch H; Störkel S; Stöckle M; Seliger B; Huber C
Hum Genet; 1996 Jun; 97(6):770-6. PubMed ID: 8641695
[TBL] [Abstract][Full Text] [Related]
22. Mutation of the Von Hippel-Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system.
Oberstrass J; Reifenberger G; Reifenberger J; Wechsler W; Collins VP
J Pathol; 1996 Jun; 179(2):151-6. PubMed ID: 8758206
[TBL] [Abstract][Full Text] [Related]
23. Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis.
Richards FM; Schofield PN; Fleming S; Maher ER
Hum Mol Genet; 1996 May; 5(5):639-44. PubMed ID: 8733131
[TBL] [Abstract][Full Text] [Related]
24. The von Hippel-Lindau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis.
Decker HJ; Weidt EJ; Brieger J
Cancer Genet Cytogenet; 1997 Jan; 93(1):74-83. PubMed ID: 9062583
[TBL] [Abstract][Full Text] [Related]
25. Should endolymphatic sac tumors be considered part of the von Hippel-Lindau complex? Pathology case report.
Tibbs RE; Bowles AP; Raila FA; Fratkin JD; Hutchins JB
Neurosurgery; 1997 Apr; 40(4):848-55; discussion 855. PubMed ID: 9092862
[TBL] [Abstract][Full Text] [Related]
26. Molecular genetic analysis of the von Hippel-Lindau disease (VHL) tumour suppressor gene in gonadal tumours.
Foster K; Osborne RJ; Huddart RA; Affara NA; Ferguson-Smith MA; Maher ER
Eur J Cancer; 1995 Dec; 31A(13-14):2392-5. PubMed ID: 8652274
[TBL] [Abstract][Full Text] [Related]
27. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
[TBL] [Abstract][Full Text] [Related]
28. [Does hemangioblastoma exist outside von Hippel-Lindau disease?].
Richard S; Beigelman C; Gerber S; Van Effenterre R; Gaudric A; Sahel M; Binaghi M; De Kersaint-Gilly A; Houtteville JP; Brunon JP
Neurochirurgie; 1994; 40(3):145-54. PubMed ID: 7723921
[TBL] [Abstract][Full Text] [Related]
29. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Marti HH; Plate KH
Blood; 1998 Nov; 92(9):3388-93. PubMed ID: 9787178
[TBL] [Abstract][Full Text] [Related]
30. DNA-based diagnosis of the von Hippel-Lindau syndrome.
Patel RJ; Appukuttan B; Ott S; Wang X; Stout JT
Am J Ophthalmol; 2000 Feb; 129(2):258-60. PubMed ID: 10682986
[TBL] [Abstract][Full Text] [Related]
31. An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects.
Webster AR; Richards FM; MacRonald FE; Moore AT; Maher ER
Am J Hum Genet; 1998 Oct; 63(4):1025-35. PubMed ID: 9758595
[TBL] [Abstract][Full Text] [Related]
32. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.
Stratmann R; Krieg M; Haas R; Plate KH
J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235
[TBL] [Abstract][Full Text] [Related]
33. Detection of a novel germline mutation in the von Hippel-Lindau tumour-suppressor gene by fluorescence-labelled base excision sequence scanning (F-BESS).
Brieger J; Weidt EJ; Gansen K; Decker HJ
Clin Genet; 1999 Sep; 56(3):210-5. PubMed ID: 10563480
[TBL] [Abstract][Full Text] [Related]
34. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene.
Stolle C; Glenn G; Zbar B; Humphrey JS; Choyke P; Walther M; Pack S; Hurley K; Andrey C; Klausner R; Linehan WM
Hum Mutat; 1998; 12(6):417-23. PubMed ID: 9829911
[TBL] [Abstract][Full Text] [Related]
35. Von Hippel-Lindau (VHL) gene analysis in Italian families with VHL disease.
Montera M; Bellone E; Ajmar F; Mandich P
Contrib Nephrol; 1997; 122():109-11. PubMed ID: 9399050
[No Abstract] [Full Text] [Related]
36. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease.
Kawahara N; Kume H; Ueki K; Mishima K; Sasaki T; Kirino T
Neurology; 1999 Jul; 53(1):208-10. PubMed ID: 10408561
[TBL] [Abstract][Full Text] [Related]
37. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
[TBL] [Abstract][Full Text] [Related]
38. Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC.
Gallou C; Joly D; Méjean A; Staroz F; Martin N; Tarlet G; Orfanelli MT; Bouvier R; Droz D; Chrétien Y; Maréchal JM; Richard S; Junien C; Béroud C
Hum Mutat; 1999; 13(6):464-75. PubMed ID: 10408776
[TBL] [Abstract][Full Text] [Related]
39. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
40. Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas.
Fogt F; Vortmeyer AO; Stolte M; Mueller E; Mueller J; Noffsinger A; Poremba C; Zhuang Z
Hum Pathol; 1998 Sep; 29(9):961-4. PubMed ID: 9744312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
